Viridian Therapeutics
(NASDAQ) VRDN
Viridian Therapeutics Financials at a Glance
Market Cap
$1.93B
Revenue (TTM)
$70.85M
Net Income (TTM)
$342.60M
EPS (TTM)
$-3.81
P/E Ratio
-4.95
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$18.82
Volume
102,272
Open
$18.83
Price
$18.82
Volume
102,272
Open
$18.83
Previous Close
$18.82
Daily Range
$18.46 - $19.22
52-Week Range
$9.90 - $34.29
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$18.82
Volume
102,272
Open
$18.83
Previous Close
$18.82
Daily Range
$18.46 - $19.22
52-Week Range
$9.90 - $34.29
VRDN News
VRDN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Viridian Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
252
CEO
Stephen Frank Mahoney, MBA
Website
www.viridiantherapeutics.comHeadquarters
Waltham, MA 02453, US
VRDN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-5%
Net Income Margin
-5%
Return on Equity
-47%
Return on Capital
-44%
Return on Assets
-38%
Earnings Yield
-20.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.93B
Shares Outstanding
102.21M
Volume
102.27K
Short Interest
0.00%
Avg. Volume
1.74M
Financials (TTM)
Gross Profit
$69.69M
Operating Income
$363.39M
EBITDA
$336.49M
Operating Cash Flow
$276.39M
Capital Expenditure
$495.00K
Free Cash Flow
$276.89M
Cash & ST Invst.
$874.65M
Total Debt
$50.69M
Viridian Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$132.00K
+83.3%
Gross Profit
$188.00K
-361.1%
Gross Margin
-1.42%
N/A
Market Cap
$1.93B
N/A
Market Cap/Employee
$13.47M
N/A
Employees
143
N/A
Net Income
$120.36M
-51.0%
EBITDA
$114.09M
-44.9%
Quarterly Fundamentals
Net Cash
$823.96M
+18.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$49.94M
+142.6%
Short Term Debt
$753.00K
+46.8%
Return on Assets
-38.09%
N/A
Return on Invested Capital
-43.85%
N/A
Free Cash Flow
$23.99M
+67.3%
Operating Cash Flow
$23.75M
+67.6%